The oral glucose tolerance test (OGTT) revisited (Q22252223)

Europe PubMed Central

title

The oral glucose tolerance test (OGTT) revisited (English)

0 references

0 references

E. Bartoli

1

E

Bartoli

1 reference

8 February 2023

G.P. Fra

series ordinal

2

author given names

G P

author last names

Fra

1 reference

8 February 2023

G.P. Carnevale Schianca

series ordinal

3

author given names

G P

author last names

Carnevale Schianca

1 reference

European Journal of Internal Medicine

8 February 2023

language of work or name

English

0 references

publication date

February 2011

0 references

published in

1 reference

Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. American Diabetes Association.

volume

22

0 references

issue

1

0 references

page(s)

8-12

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Loss of beta cell function as fasting glucose increases in the non-diabetic range

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Individuation of different metabolic phenotypes in normal glucose tolerance test

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

The OGTT as test for beta cell function?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Poor specificity of fasting plasma glucose cut-off values in ruling out glucose intolerance: the complementary usefulness of OGTT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Obesity and diabetes in the developing world--a growing challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award Lecture, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

A1C and diabetes diagnosis: The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

A1C for screening and diagnosis of type 2 diabetes in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Impaired glucose tolerance. Why is it not a disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Assessing the shape of the glucose curve during an oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJIM.2010.07.008

7 January 2021

10.1016/J.EJIM.2010.07.008

Identifiers

DOI

0 references